Home › Funds › Gagnon Advisors, LLC › PCRX

Gagnon Advisors, LLC position in PCRX

PACIRA BIOSCIENCES INC · Health Care

Gagnon Advisors, LLC reported holding 352,637 shares of PCRX (PACIRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$8.8M, representing 4.85% of its reported portfolio and ranking #10 among its reported holdings. Gagnon Advisors, LLC has disclosed PCRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)352.64K sh
Reported value held$8.83M
Portfolio Weight4.85%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Gagnon Advisors, LLC's PCRX position evolved

Gagnon Advisors, LLC first disclosed a stake in PCRX in Q3 2023 at 180,331 shares (US$5.5M). The position peaked in Q2 2026 at 352,637 shares, worth US$8.9M. Across 13 filings, Gagnon Advisors, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 352,637 shares valued at US$8.8M. Notable position changes include a 26% trim in Q4 2023 (shares fell 13% over the following quarter), a 60% increase in Q2 2025 (shares rose 8% over the following quarter), a 35% increase in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 180.33K $5.53M New
Q4 2023 133.39K $4.50M Reduce
Q1 2024 133.39K $3.90M Hold
Q2 2024 133.39K $3.82M Hold
Q3 2024 133.39K $2.01M Hold
Q4 2024 133.39K $2.51M Hold
Q1 2025 133.39K $3.31M Hold
Q2 2025 213.40K $5.10M Add
Q3 2025 213.40K $5.50M Hold
Q4 2025 260.91K $6.75M Add
Q1 2026 352.64K $7.97M Add
Q2 2026 352.64K $8.95M Hold
Q3 2026 352.64K $8.83M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCRX and 13F data

PCRX (PACIRA BIOSCIENCES INC) is a Health Care company. 21 other funds we track also report a position in PCRX — the largest reported positions include Context Capital Management, LLC (US$87.0M), Doma Perpetual Capital Management LLC (US$70.5M), GAGNON SECURITIES LLC (US$15.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCRX

All PCRX fund holders →

FAQ

How long has Gagnon Advisors, LLC held PCRX?

Gagnon Advisors, LLC has disclosed PCRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Gagnon Advisors, LLC's current position in PCRX?

As of Q3 2026, Gagnon Advisors, LLC holds 352.64K shares of PCRX (PACIRA BIOSCIENCES INC), valued at $8.83M, representing 4.85% of its reported portfolio and ranking #10.

Has Gagnon Advisors, LLC been buying or selling PCRX?

In the latest 13F filing (Q3 2026), Gagnon Advisors, LLC held unchanged its position in PCRX. The position peaked in Q2 2026 at 352.64K shares.

Which other funds hold PCRX?

Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, GAGNON SECURITIES LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.